학술논문
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
Document Type
Article
Author
Bánki, Zoltán; Kimpel, Janine; Rössler, Annika; Schäfer, Helena; Falkensammer, Barbara; Bante, David; Krammer, Florian; von Laer, Dorothee; Borena, Wegene; Forer, Lukas; Schönherr, Sebastian; Sacher, Magdalena; Ower, Cornelia; Harthaller, Teresa; Neurauter, Bianca; Hochmuth, Eva; Hoch, Luiza; Huber, Maria; Müllauer, Brigitte; Peer, Evelyn; Raschbichler, Lisa-Maria; Falch, Albert; Embacher-Aichhorn, Sabine; Becker, Kathrin; Seekircher, Lisa; Tschiderer, Lena; Ulmer, Hanno; Willeit, Peter
Source
In The Lancet Microbe
Subject
Language
ISSN
2666-5247